Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.65 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.37 |
| ▸ | NPFFR1 | Q9GZQ6 | 4/20 | 0.37 |
| ▸ | NPFFR2 | Q9Y5X5 | 4/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7656338 | 0.95 | HRH3 (0.66) | HRH3DPP8NPFFR1NPFFR2OPRM1 | |
| SCHEMBL7659427 | 0.93 | HRH3 (0.67) | HRH3NPFFR1NPFFR2OPRM1OPRK1 | |
| SCHEMBL7657287 | 0.93 | HRH3 (0.64) | HRH3NPFFR1NPFFR2OPRM1OPRK1 | |
| SCHEMBL7661605 | 0.90 | HRH3 (0.64) | HRH3DPP8NPFFR1NPFFR2OPRM1 | |
| SCHEMBL7663692 | 0.88 | HRH3 (0.67) | HRH3DPP8NPFFR1NPFFR2OPRL1 | |
| SCHEMBL7665094 | 0.87 | HRH3 (0.60) | HRH3DPP8NPFFR1NPFFR2OPRM1 | |
| SCHEMBL7662209 | 0.86 | HRH3 (0.59) | HRH3DPP8NPFFR1NPFFR2OPRM1 | |
| SCHEMBL7654053 | 0.85 | HRH3 (0.60) | HRH3NPFFR1NPFFR2OPRM1OPRK1 | |
| SCHEMBL7654578 | 0.85 | HRH3 (0.65) | HRH3NPFFR1NPFFR2OPRL1 | |
| SCHEMBL7663686 | 0.85 | HRH3 (0.65) | HRH3DPP8NPFFR1NPFFR2OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6469002-B1 | COMPOUNDS WHICH MODULATE CHEMOKINE RECEPTOR ACTIVITY AND ARE USEFUL IN TREATMENT OF INFLAMMATORY DISEASES | MILLENNIUM PHARMACEUTICALS, INC. | 2002-10-22 | — | — | US | disclosed |